Advanced or Recurrent Endometrial Cancer Clinical Trial
0 Visningar
• 07/09/23
0
0
Bädda in
administrator
Prenumeranter
The purpose of this clinical trial is to study the good and bad effects of adding the PD-1 inhibitor called pembrolizumab to standard treatment for advanced or recurrent endometrial cancer. http://www.bigtencrc.org
Visa mer
Facebook-kommentarer
SORT BY-
Toppkommentarer
-
Senaste kommentarerna